FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Guy Amsden

Research Profile

Chemicals & Drugs

Procedures

Physiology

Concepts & Ideas

Co-author Network

Publications

TOP 3
Ahmed El-Tahtawy; Paul Glue; Emma N Andrews; Jack Mardekian; Guy W Amsden; Charles A Knirsch
The effect of azithromycin on ivermectin pharmacokinetics--a population pharmacokinetic model analysis.
Guy W Amsden; Thomas B Gregory; Cheryl A Michalak; Paul Glue; Charles A Knirsch
Pharmacokinetics of azithromycin and the combination of ivermectin and albendazole when administered alone and concurrently in healthy volunteers.
Guy W Amsden
Regulatory disincentives for developing antibiotics for common indications.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Guy Amsden (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Ahmed El-Tahtawy; Paul Glue; Emma N Andrews; Jack Mardekian; Guy W Amsden; Charles A Knirsch
The effect of azithromycin on ivermectin pharmacokinetics--a population pharmacokinetic model analysis.
PLoS neglected tropical diseases 2008;2(5):e236.
2007: Guy W Amsden; Thomas B Gregory; Cheryl A Michalak; Paul Glue; Charles A Knirsch
Pharmacokinetics of azithromycin and the combination of ivermectin and albendazole when administered alone and concurrently in healthy volunteers.
The American journal of tropical medicine and hygiene 2007;76(6):1153-7.
2007: Guy W Amsden
Regulatory disincentives for developing antibiotics for common indications.
Current infectious disease reports 2007;9(1):29-34.
2007: Guy W Amsden
Are we on the road to eliminating pneumococcal infections.
Current infectious disease reports 2007;9(1):5-6.
2007: Marcus Zervos; Fernando J Martinez; Guy W Amsden; Constance D Rothermel; Glenda Treadway
Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
International journal of antimicrobial agents 2007;29(1):56-61.
2006: Manjunath P Pai; Sarah E Allen; Guy W Amsden
Altered steady state pharmacokinetics of levofloxacin in adult cystic fibrosis patients receiving calcium carbonate.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2006;5(3):153-7.
2005: Michael A Pacanowski; Guy W Amsden
Interferon gamma-1b in the treatment of idiopathic pulmonary fibrosis.
The Annals of pharmacotherapy 2005;39(10):1678-86.
2005: Alicia A Cymbala; Lee C Edmonds; Michael A Bauer; Peter J Jederlinic; John J May; Jennifer M Victory; Guy W Amsden
The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis.
Treatments in respiratory medicine 2005;4(2):117-22.
2005: Guy W Amsden
Treatment of Legionnaires' disease.
Drugs 2005;65(5):605-14.
2005: Robert N Swanson; Alberto Lainez-Ventosilla; Maria C De Salvo; Michael W Dunne; Guy W Amsden
Once-daily azithromycin for 3 days compared with clarithromycin for 10 days for acute exacerbation of chronic bronchitis: a multicenter, double-blind, randomized study.
Treatments in respiratory medicine 2005;4(1):31-9.
2005: Guy W Amsden
Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
The Journal of antimicrobial chemotherapy 2005;55(1):10-21.
2004: Guy W Amsden
Industry sponsorship in research and publishing: who is really to blame for perceived bias?
The Annals of pharmacotherapy 2004;38(4):714-6.
2004: Constance Law; Guy W Amsden
Single-dose azithromycin for respiratory tract infections.
The Annals of pharmacotherapy 2004;38(3):433-9.
2004: Guy W Amsden
Pneumococcal resistance in perspective: how well are we combating it?
The Pediatric infectious disease journal 2004;23(2 Suppl):S125-8.
2004: Guy W Amsden; David P Nicolau; Anne-Marie Whitaker; Dana Maglio; Akintunde Bello; Rene Russo; Anthony Barros; Diptee A Gajjar
Characterization of the penetration of garenoxacin into the breast milk of lactating women.
Journal of clinical pharmacology 2004;44(2):188-92.
2004: Marcus Zervos; Lionel A Mandell; Peter S Vrooman; Charles Andrews; Andrew McIvor; Ramzan H Abdulla; Pascal J de Caprariis; Charles A Knirsch; Guy W Amsden; Michael S Niederman; Hartmut Lode
Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia.
Treatments in respiratory medicine 2004;3(5):329-36.
2003: Guy W Amsden; Robert C Owens; Joseph S Bertino
AUIC in humans: a fact-based discussion.
The Annals of pharmacotherapy 2003;37(10):1518-21.
2003: Guy W Amsden; Anne-Marie Whitaker; Patrick W Johnson
Lack of bioequivalence of levofloxacin when coadministered with a mineral-fortified breakfast of juice and cereal.
Journal of clinical pharmacology 2003;43(9):990-5.
2003: Allison W Wallace; Jennifer M Victory; Guy W Amsden
Lack of bioequivalence when levofloxacin and calcium-fortified orange juice are coadministered to healthy volunteers.
Journal of clinical pharmacology 2003;43(5):539-44.
2003: Guy W Amsden; Ian M Baird; Stuart Simon; Glenda Treadway
Efficacy and safety of azithromycin vs levofloxacin in the outpatient treatment of acute bacterial exacerbations of chronic bronchitis.
Chest 2003;123(3):772-7.
2003: Allison W Wallace; Jennifer M Victory; Guy W Amsden
Lack of bioequivalence of gatifloxacin when coadministered with calcium-fortified orange juice in healthy volunteers.
Journal of clinical pharmacology 2003;43(1):92-6.
2003: Toni C Butler; Raquel M Rosen; Allison L Wallace; Guy W Amsden
Flumazenil and dialysis for gabapentin-induced coma.
The Annals of pharmacotherapy 2003;37(1):74-6.
2002: Loretta M Chiu; A M Menhinick; P W Johnson; Guy W Amsden
Pharmacokinetics of intravenous azithromycin and ceftriaxone when administered alone and concurrently to healthy volunteers.
The Journal of antimicrobial chemotherapy 2002;50(6):1075-9.
2002: Ashley L Neuhofel; John H Wilton; Jennifer M Victory; Linda G Hejmanowsk; Guy W Amsden
Lack of bioequivalence of ciprofloxacin when administered with calcium-fortified orange juice: a new twist on an old interaction.
Journal of clinical pharmacology 2002;42(4):461-6.
2002: Guy W Amsden; Olatunde Kuye; Greg C G Wei
A study of the interaction potential of azithromycin and clarithromycin with atorvastatin in healthy volunteers.
Journal of clinical pharmacology 2002;42(4):444-9.
2002: Allison W Wallace; Guy W Amsden
Is it really OK to take this with food? Old interactions with a new twist.
Journal of clinical pharmacology 2002;42(4):437-43.
2002: Christopher S Shain; Guy W Amsden
Telithromycin: the first of the ketolides.
The Annals of pharmacotherapy 2002;36(3):452-64.
2002: Loretta M Chiu; Guy W Amsden
Intrapulmonary pharmacokinetics of antibacterial agents: implications for therapeutics.
American journal of respiratory medicine : drugs, devices, and other interventions 2002;1(3):201-9.
2002: Loretta M Chiu; Guy W Amsden
Current trachoma treatment methodologies: focus on advancements in drug therapy.
Drugs 2002;62(18):2573-9.
2002: Manfred Hauben; Guy W Amsden
The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental?
Drug safety : an international journal of medical toxicology and drug experience 2002;25(13):929-42.
2001: Guy W Amsden; J Flaherty; D Luke
Lack of an effect of azithromycin on the disposition of zidovudine and dideoxyinosine in HIV-infected patients.
Journal of clinical pharmacology 2001;41(2):210-6.
2001: Guy W Amsden
Advanced-generation macrolides: tissue-directed antibiotics.
International journal of antimicrobial agents 2001;18 Suppl 1():S11-5.
2001: Guy W Amsden; J M Duran
Interpretation of antibacterial susceptibility reports: in vitro versus clinical break-points.
Drugs 2001;61(2):163-6.
2001: Guy W Amsden; C L Gray
Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteers.
The Journal of antimicrobial chemotherapy 2001;47(1):61-6.
2000: Guy W Amsden; Anne N Nafziger; G Foulds; L J Cabelus
A study of the pharmacokinetics of azithromycin and nelfinavir when coadministered in healthy volunteers.
Journal of clinical pharmacology 2000;40(12 Pt 2):1522-7.
2000: Manjunath P Pai; DM Graci; Guy W Amsden
Macrolide drug interactions: an update.
The Annals of pharmacotherapy 2000;34(4):495-513.
2000: J M Duran; Guy W Amsden
Azithromycin: indications for the future?
Expert opinion on pharmacotherapy 2000;1(3):489-505.
2000: Guy W Amsden; G Foulds; K Thakker
Pharmacokinetic study of azithromycin with fluconazole and cotrimoxazole (trimethoprim-sulfamethoxazole) in healthy volunteers.
Clinical drug investigation 2000;20(2):135-42.
1999: Guy W Amsden; DM Graci; L J Cabelus; L G Hejmanowski
A randomized, crossover design study of the pharmacology of extended-spectrum fluoroquinolones for pneumococcal infections.
Chest 1999;116(1):115-9.
1999: Scott A McConnell; Anne N Nafziger; Guy W Amsden
Lack of effect of dirithromycin on theophylline pharmacokinetics in healthy volunteers.
The Journal of antimicrobial chemotherapy 1999;43(5):733-6.
1999: KW Garey; C A Peloquin; P G Godo; A N Nafziger; Guy W Amsden
Lack of effect of zafirlukast on the pharmacokinetics of azithromycin, clarithromycin, and 14-hydroxyclarithromycin in healthy volunteers.
Antimicrobial agents and chemotherapy 1999;43(5):1152-5.
1999: Scott A McConnell; Guy W Amsden
Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin.
Pharmacotherapy 1999;19(4):404-15.
1999: Guy W Amsden
Pharmacological considerations in the emergence of resistance.
International journal of antimicrobial agents 1999;11 Suppl 1():S7-14; discussion S31-2.
1999: KW Garey; Guy W Amsden
Intravenous azithromycin.
The Annals of pharmacotherapy 1999;33(2):218-28.
1999: KW Garey; Guy W Amsden
Trovafloxacin: an overview.
Pharmacotherapy 1999;19(1):21-34.
1999: Guy W Amsden; Anne N Nafziger; G Foulds
Pharmacokinetics in serum and leukocyte exposures of oral azithromycin, 1,500 milligrams, given over a 3- or 5-day period in healthy subjects.
Antimicrobial agents and chemotherapy 1999;43(1):163-5.
1998: Guy W Amsden; KL Cheng; C A Peloquin; Anne N Nafziger
Oral cimetidine prolongs clarithromycin absorption.
Antimicrobial agents and chemotherapy 1998;42(7):1578-80.
1998: EF Trépanier; Anne N Nafziger; G L Kearns; Angela D M Kashuba; Guy W Amsden
Absence of effect of terbinafine on the activity of CYP1A2, NAT-2, and xanthine oxidase.
Journal of clinical pharmacology 1998;38(5):424-8.
1998: KL Cheng; Anne N Nafziger; C A Peloquin; Guy W Amsden
Effect of grapefruit juice on clarithromycin pharmacokinetics.
Antimicrobial agents and chemotherapy 1998;42(4):927-9.
1998: EF Trépanier; Anne N Nafziger; Guy W Amsden
Effect of terbinafine on theophylline pharmacokinetics in healthy volunteers.
Antimicrobial agents and chemotherapy 1998;42(3):695-7.
1998: Angela D M Kashuba; Guy W Amsden
Bronchopulmonary pharmacokinetics of clarithromycin and azithromycin.
Antimicrobial agents and chemotherapy 1998;42(2):481-2.
1998: EF Trépanier; Guy W Amsden
Current issues in onychomycosis.
The Annals of pharmacotherapy 1998;32(2):204-14.
1997: KL Cheng; P N Dwyer; Guy W Amsden
Paradoxic excitation with diphenhydramine in an adult.
Pharmacotherapy 1997;17(6):1311-4.
1997: KW Garey; Guy W Amsden; C A Johns
Possible interaction between imipramine and butalbital.
Pharmacotherapy 1997;17(5):1041-2.
1996: Guy W Amsden; CH Ballow
Prospective validation of an optimal sparse plasma-sampling strategy for estimating ciprofloxacin pharmacokinetics.
Pharmacotherapy 1996;16(5):937-41.
1996: Guy W Amsden; F Georgian
Orthostatic hypotension induced by sertraline withdrawal.
Pharmacotherapy 1996;16(4):684-6.
1992: CH Ballow; Guy W Amsden
Azithromycin: the first azalide antibiotic.
The Annals of pharmacotherapy 1992;26(10):1253-61.
1992: Guy W Amsden; S F Kowalsky; G D Morse
Trimetrexate for Pneumocystis carinii pneumonia in patients with AIDS.
The Annals of pharmacotherapy 1992;26(2):218-26.